Aster DM Healthcare Q4 profits surge on merger boost

4 May 2026via WhalesbookSource

English हिंदी తెలుగు தமிழ்ಕನ್ನಡ मराठी বাংলা ગુજરાતી

Aster DM Healthcare Q4 profits surge on merger boost — The company reported strong Q4 earnings driven by its recent merger, with consolidated revenue rising 28% YoY to ₹1,450 crore and EBITDA margin expanding to 24.3%. However, analysts are questioning its stretched valuation amid competitive pressures. A review by Whalesbook highlights integration risks despite robust top-line growth.

📊 STOCKS: ASTERDM | 🏢 SECTOR: Healthcare | #HIGHIMPACT #Earnings

#Earnings#Merger#Valuation

Stocks mentioned

ASTERDMAster DM Healthcare Limited

⚠️ This brief is AI-generated from public news sources for informational purposes only. Not investment advice. Always consult a SEBI-registered advisor before trading.

Trade smarter on NSE

Live option chains, FII flows, PCR, AI analysis — for NIFTY, BANKNIFTY & 200+ F&O stocks.

Start for ₹1 →